000			02071 a2200577 4500
005			20250517114142.0
264		0	_c20170227
008			201702s 0 0 eng d
022			_a1742-7843
024	7		_a10.1111/bcpt.12667 _2doi
040			_aNLM _beng _cNLM
100	1		_aKaraca, R Ozgur
245	0	0	_aEffects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication. _h[electronic resource]
260			_bBasic & clinical pharmacology & toxicology _cFeb 2017
300			_a199-206 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a2-Pyridinylmethylsulfinylbenzimidazoles _xadministration & dosage
650	0	4	_aATP Binding Cassette Transporter, Subfamily B _xgenetics
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aBiotransformation
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aCytochrome P-450 CYP2C19 _xgenetics
650	0	4	_aCytochrome P-450 CYP3A _xgenetics
650	0	4	_aCytochrome P-450 Enzyme System _xgenetics
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aGastritis _xdrug therapy
650	0	4	_aGenotype
650	0	4	_aHelicobacter Infections _xdiagnosis
650	0	4	_aHelicobacter pylori _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPantoprazole
650	0	4	_aPeptic Ulcer _xdrug therapy
650	0	4	_aPharmacogenetics
650	0	4	_aPhenotype
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aProton Pump Inhibitors _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aKalkisim, Said
700	1		_aAltinbas, Akif
700	1		_aKilincalp, Serta
700	1		_aYuksel, Ilhami
700	1		_aGoktas, Mustafa T
700	1		_aYasar, Umit
700	1		_aBozkurt, Atilla
700	1		_aBabaoglu, Melih O
773	0		_tBasic & clinical pharmacology & toxicology _gvol. 120 _gno. 2 _gp. 199-206
856	4	0	_uhttps://doi.org/10.1111/bcpt.12667 _zAvailable from publisher's website
999			_c26404332 _d26404332